A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Insulin beef
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Insulin beef.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Lixisenatide
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Lixisenatide.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Ciglitazone
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Ciglitazone.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Rivoglitazone
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Rivoglitazone.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Netoglitazone
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Netoglitazone.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Dulaglutide
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Dulaglutide.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Albiglutide
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Albiglutide.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Benfluorex
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Benfluorex.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Glibornuride
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Glibornuride.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Gosogliptin
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Gosogliptin.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Liraglutide
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Liraglutide.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Alogliptin
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Alogliptin.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Bisegliptin
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Bisegliptin.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
AMG-222
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with AMG-222.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
NBI-6024
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with NBI-6024.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
NN344
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with NN344.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Voglibose
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Voglibose.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Vildagliptin
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Vildagliptin.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
AICA ribonucleotide
The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with AICA ribonucleotide.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Milnacipran
The metabolism of Milnacipran can be increased when combined with Prednisolone acetate.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3